- Raised $200M Public Offering, Oct 2016
- Raised $200M Public Offering, Sep 2014
- Raised $100M Public Offering, Jan 2013
About
Compugen is a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery. The company has been at the forefront of decoding cancer biology with its AI-powered predictive computational discovery platform, Unigen™. Unigen™ combines deep scientific knowledge, AI/ML predictive algorithms, and a cloud-based, technology-agnostic platform integrating various biological data. The outcomes from preclinical and clinical trials enrich its proprietary knowledgebase to discover additional novel drug targets and further understand complex biology. To date, Unigen™ has yielded multiple novel immuno-oncology drug targets, potential first or best-in-class clinical stage immuno-oncology programs, validating partnerships with multiple pharmaceutical companies, and undisclosed programs in its early-stage pipeline.
Funding history · 13 rounds · $804.0M total
Offices
Q&A
- What is Compugen's primary focus?
- Compugen is a clinical-stage cancer immunotherapy company that uses an AI-powered predictive computational discovery platform, Unigen™, to identify novel drug targets and develop cancer immunotherapies.
- When was Compugen founded and where is it headquartered?
- Compugen was founded in February 1993 and is headquartered in Holon, Israel.
- What is Compugen's current employee count?
- Compugen has 51-200 employees.
- How much funding has Compugen raised in total?
- Compugen has raised a total of $804,000,011.15 USD.
- When was Compugen's most recent public offering?
- Compugen had a public offering in January 2023, raising $50,000,000.
- Which investors participated in Compugen's B Round funding?
- Compugen's B Round in July 2000, which raised $35,000,000, included Apax and Yozma Group Korea among its lead investors.
- Who are the founders of Compugen?
- The founders of Compugen are Eli Mintz, Simchon Faigler, and Amir Natan.
- What is the name of Compugen's AI-powered discovery platform?
- Compugen's AI-powered predictive computational discovery platform is called Unigen™.
Team · 18
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | cgen.com/ |
|---|---|
| linkedin.com/company/753626 | |
| X / Twitter | twitter.com/CompugenLtd |
| Wikipedia | en.wikipedia.org/wiki/Compugen_Ltd. |
| Wikidata | wikidata.org/wiki/Q5157220 |
Identifiers & details
| Legal name | Compugen Ltd. |
|---|---|
| Founded | 1993-2 |
| Employees (exact) | 75 |
| Wikidata QID | Q5157220 |
Radar intelligence
Open jobs — comeet
| Total open | 2 |
|---|---|
| Remote | 0 |
| By department | Drug Discovery and Validation (1), Immuno-Oncology Research (1) |
| By location | Israel (2) |
| Title | Location | Department |
|---|---|---|
| Senior Scientist, Antibody Engineering & Discovery | Israel | Drug Discovery and Validation |
| Research Lab Technician | Israel | Immuno-Oncology Research |
Patents
| EPO | 156 |
|---|
Publications (Crossref)
| Works | 10 |
|---|
Web history (Wayback)
| Domain | cgen.com |
|---|
Wikidata
| QID | Q5157220 |
|---|
Certificate / subdomain footprint
| Subdomains | 20 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 511779639 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה ציבורית |
| Incorporated | 1993-02-10 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 1998 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | הרוקמים 26 חולון |